Escalon Medical Corp.
ESMC
$0.19
-$0.02-9.52%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.31M | 11.94M | 12.05M | 12.95M | 12.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.31M | 11.94M | 12.05M | 12.95M | 12.17M |
| Cost of Revenue | 6.91M | 6.52M | 6.54M | 7.09M | 6.79M |
| Gross Profit | 5.40M | 5.42M | 5.51M | 5.86M | 5.38M |
| SG&A Expenses | 4.80M | 4.63M | 4.62M | 4.58M | 4.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.51M | 11.98M | 11.91M | 12.30M | 11.96M |
| Operating Income | -199.90K | -42.70K | 133.10K | 643.20K | 210.60K |
| Income Before Tax | -250.50K | -102.20K | 105.50K | 619.70K | 186.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.25 | -0.10 | 0.11 | 0.62 | 0.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -250.50K | -102.20K | 105.50K | 619.70K | 186.10K |
| EBIT | -199.90K | -42.70K | 133.10K | 643.20K | 210.60K |
| EBITDA | -165.80K | -7.20K | 171.10K | 691.90K | 254.10K |
| EPS Basic | -0.04 | -0.03 | 0.00 | 0.05 | 0.00 |
| Normalized Basic EPS | -0.02 | -0.01 | 0.01 | 0.05 | 0.02 |
| EPS Diluted | -0.04 | -0.03 | 0.00 | 0.04 | 0.00 |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.01 | 0.03 | 0.01 |
| Average Basic Shares Outstanding | 29.66M | 29.66M | 29.66M | 29.66M | 29.66M |
| Average Diluted Shares Outstanding | 43.42M | 43.08M | 43.08M | 43.08M | 36.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |